A Distinct Replication Fork Protection Pathway Connects Fanconi Anemia Tumor Suppressors to RAD51-BRCA1/2

Schlacher, Katharina, Wu, Hong, Jasin, Maria·2012·Cancer Cell
DOI 10.1016/j.ccr.2012.05.015

Cited by (930)

Items 901–930 of 930

  1. Impact de l'haplo-insuffisance de HIRA sur l'organisation de la chromatine au cours de la différenciation neuronale
    Jean-Philippe Trani · 2022 · theses.fr (ABES)
  2. Exploration de la sensibilité au stress réplicatif dans les cancers du sein triple négatifs BRCA déficients
    Imène Tabet · 2023 · theses.fr (ABES)
  3. Shedding light on the mechanisms of tumor formation linked to BRCA2 using two known pathogenic variants
    Anna Minello · 2023 · theses.fr (ABES)
  4. Factors that contribute to B cell oncogenesis in people living with HIV
    Anna Shmakova · 2023 · theses.fr (ABES)
  5. Targeting the cell cycle : A novel therapeutic strategy against ATIP3- deficient breast cancer
    Maria M. Haykal · 2023 · theses.fr (ABES)
  6. Functional assays for BRCA1 and BRCA2 variant analysis: new tools and their applications
    Muthiah Bose, Elangoli Ebrahimkutty Faseela, Maria Rossing, Claus Storgaard Sørensen · 2026 · npj Breast Cancer
  7. Comprehensive Analysis Reveals Adaptive DNA Repair and Replication Stress Networks in Genomically Unstable Breast Cancer
    Farah Ramadan, Sara Zahraeifard, Neelima Yadav, Ujwal Subedi, Sameer Shah, Arvind Panday · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  8. RAD54L promotes nascent DNA degradation and radial chromosome formation in FANC-deficient cells
    Zane Tolbert, Samantha Reed, Steven Goodson, Jennifer M. Mason · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  9. DDX5 (p68) and UbE2T as emerging superior cancer therapeutic targets: dual molecular glue target degradation by FL118 for conquering difficult-to-treat cancers
    Fengzhi Li, Xiang Ling, Sayan Chakraborty, Dean G. Tang, Karen McLean, Wenjie Wu, Norbert Süle, Deepak Vadehra, Christos K Fountzilas, Ajay Gupta et al. · 2026 · Journal of Experimental & Clinical Cancer Research
  10. FBH1 and RAD54L directly interact and cooperate to drive replication fork reversal
    Mollie E. Uhrig, Courtney N. Johnson, Jordi Gómez, Alexander V. Mazin, Claudia Wiese · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  11. BRCA1/2 Reversion Mutations and Cancer Therapy Resistance
    Wenjing Qi, Gege Yang, Yingyi Zhang, Liping Han, Kevin H. Mayo, Xianlu Zeng, Jingang Mo · 2026 · Biology
  12. Functions and mechanisms of BRCA1 in early embryonic development
    Lily Acker, Hui Chen (28597) · 2026 · Cells and Development
  13. FANCI: from genome guardian to translational therapeutic target
    X Zhang, Yang Zhang, Mengying Chen, Jinmei Wei, Yuanyuan Li, Tao Dai, Junyu He, Chen Han, Yanhong Zhou · 2026 · Frontiers in Oncology
  14. Heterogeneous CRISPR/Cas9 Editing of HMOX1 Is Associated with Altered Heme–Biliverdin Metabolism and Basal Stress-Associated Transcriptional Programs in Chicken LMH Cells
    Haonan Tang, Huaiyu Li, Yurong Tai, Xue Yang, Letian Zhang, Yuhao Ma, Ganxian Cai, Hongyang Zhao, Tong Zeng, Xiaohua Ai et al. · 2026 · International Journal of Molecular Sciences
  15. Nucleostemin promotes RAD51 filament assembly on double-stranded DNA to protect stalled replication forks
    Chih-Chun Chang, Siang-Sheng Tsai, Chang-Le Chou, Yi-Hsuan Chang, Chia-Tai Hung, Robert Y. L. Tsai, Hung‐Wen Li, Hungjiun Liaw, Peter Chi · 2026 · Nucleic Acids Research
  16. Nuclear amphiregulin and lamin A contribute to genomic stability and the response to replication stress via regulation of heterochromatin
    Tianqi Jiang, Aiman A. Zein, M.A. Christine Pratt · 2026 · Oncogene
  17. PCNA–RECQL5–RPRD1B recruit repair components to stressed replication forks to promote survival of BRCA1-deficient cancer cells
    Manh Tien Tran, Elizabeth A. Williamson, Aruna Shanker Jaiswal, Dominic Arris, Nhat Nguyen, Andrew Carrillo, Shaun Olsen, Kimi Kong, Montasser Shaheen, Doraid Sadadeen et al. · 2026 · Nucleic Acids Research
  18. Targeting the FBXL12–FANCD2 Pathway Disrupts Replication Stress Tolerance in MYCN-Driven Neuroblastoma
    Jinjiang Chou, Alena Malyukova, Alessandro Simone Bordonaro, Krzysztof Dygon, Lena Litzenburger, Ervelina Dalani, Jiayu Xiao, Conny Tümmler, Georgios Mermelekas, Janith Seniveratne et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  19. Distinct functions of mammalian RAD51 paralogs in genome maintenance
    Harsh Kumar Dwivedi, Debanjali Bhattacharya, Shariva Kadupatil, Ganesh Nagaraju · 2026 · Biochemical Society Transactions
  20. FANCM restrains structural genome evolution and defines a synthetic lethal dependency in BRCA1 -deficient breast cancer
    Farah Ramadan, Sameer Bikram Shah, Ujwal Subedi, Zachary D. Stephens, Annapoorna Venkatachalam, Neelima Yadav, Vickky Pandit, Sadhana Dubey, Sarah Latka, Hugo Villanueva et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  21. Replication-coupled chromatin assembly cooperates with ATR/CHK1 signaling to suppress DNA damage and premature MMB-dependent mitotic transcription
    Devi Bala Murugan, Dörthe Gertzmann, Merima Ramic, Nils Greim, Aikaterini Boura, Karen M Auweiler, Lea Damaschke, Christina Schuelein‐Voelk, Carsten Patrick Ade, Martin Eilers et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  22. Understanding mechanisms of PARP inhibitor resistance
    Josep V. Forment, Mark J. O’Connor · 2026 · npj Breast Cancer
  23. Expanding the therapeutic scope of PARP inhibitors in breast cancer: current indications and future directions
    Charlotte S. Walmsley, Adela Rodriguez, Panagiotis A. Konstantinopoulos, Geoffrey Ira Shapiro, Sara M. Tolaney, Judy Ellen Garber, Filipa C. Lynce · 2026 · Journal of Clinical Investigation
  24. A genome-scale adaptation map identifies the FANCM-RMI1/2 complex as an opposing modulator of cell fitness upon BRCA1 or BRCA2 loss
    François Dossin, Mikaël Attia, Fabricio Montero Zuniga, Daniel González‐Acosta, Rachel Brough, Fei Song, Dragomir B. Krastev, Maya Raghunandan, Stephen J. Pettitt, Aurélien Bore et al. · 2026 · Molecular Cell
  25. ATM promotes nucleolytic processing of reversed replication forks during DNA interstrand cross-link repair
    Maria Altshuller, Guojun Shi, Victoria A. MacKrell, Jasmine Tzeng, Richa Nigam, Jade K. Konsler, Ting‐Yu Wang, Yixing Wang, Emma Grogan, Obehi E Ozua et al. · 2026 · Nature Communications
  26. EXO1 inhibition selectively kills replication repair-deficient cancer cells
    Marija Maric, Sarah Elizabeth McClelland, Simon J. Boulton · 2026 · NAR Cancer
  27. Small molecules targeting BRCA1 -deficient cancer cells
    Arunasalam Navaraj, Shengliang Zhang, Christopher Egg-Krings, Kevin Si, Jean‐Nicolas Gallant, Jay Gopal, Sriya S.P. Datla, David T. Dicker, Dinara Ryspayeva, Wafik S. El‐Deiry · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  28. BindingDB Entry 50021816: Poly (ADP-ribose) polymerase (PARP) inhibitors as anticancer agents: An outlook on clinical progress, synthetic strategies, biological activity, and structure-activity relationship.
    BindingDB · 2025 · UC San Diego
  29. BindingDB Entry 7477: Cellularly active N-hydroxyurea FEN1 inhibitors block substrate entry to the active site.
    BindingDB · 2016 · UC San Diego
  30. Repair of replication-born DNA lesions before and during mitosis
    H. Rudolf de Boer, Marcel A.T.M. van Vugt · 2026 · DNA repair